GENE ONLINE|News &
Opinion
Blog

Merck KGaA
GeneOnline’s Pick: Top 10 Global Industry News Stories in 2023 (Part 1)
2024-01-08
GeneOnline’s Weekly News Highlights: Sept 25-Sept 29
2023-10-03
Merck KGaA Extends Collaboration with Quris-AI for Groundbreaking Advancements in Drug Safety
2023-10-02
PDS Buys IL-12 Targeting Therapy From Merck KGaA for $121 Million Biobucks
2023-01-04
Proxygen Eligible For €495 Million in Molecular Glue Degrader Collaboration with Merck KGaA
2022-06-06
FDA Approval of Tepotinib Sets Stage for Merck Versus Novartis Showdown in Metastatic NSCLC Space
2021-02-05
R&D
ASCO 2020: Maintenance Therapy with Avelumab Post-Chemo Improves Overall Survival of Bladder Cancer Patients
2020-05-29
Weekly in Asia|Nov-2
2019-11-27
BIO Asia Taiwan Review: The AI Tide, How Informatics Shape the Future of Pharmaceutical Industry
2019-08-12
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top